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To assess the efficacy of surgical revascularization for
postinfarction angina within 30 days of acute infarction,
the clinical course of 103patients treated surgically from
January 1979 to July 1982 was reviewed. There were 84
men (82%) and 19 women (18%) with a mean age of 58
years (range 34 to 80). Group A (11 patients) underwent
surgery within 24 hours of infarction, Group B (21 pa-
tients) within 7 days and Group C (71 patients) within
30 days. Eighty-four patients (82%) had subendocardial
infarctions and 19 patients (18%) had transmural in-
farction. Transmural infarction was more common in
patients in Group A (36%) than in those in either Group
B (19%) or Group C (15%). There were two deaths,
both in Group C (1.9%), within 30 days of surgery. The
use of intraaortic balloon or inotropic support and the
Controversy persists among some cardiologists and surgeons
with regard to surgical myocardial revascularization for per-
sistent or recurrent angina early after established acute myo-
cardial infarction. Persistent or recurrent angina after in-
farction implies the existence of viable but ischemic
myocardium either surrounding the infarct zone or distal to
it. The incidence of infarct extension in patients with per-
sistent or recurrent angina who are treated medically varies
from 13 to 86% and is associated with a poor prognosis
within the first year (1-4). Early myocardial revascu1ari-
zation, therefore, may be an attractive therapeutic alterna-
tive to prolonged medical management in some patients with
postinfarction angina in an attempt to salvage ischemic myo-
cardium and reduce infarct extension.
The first reports (5-12) of patients undergoing surgical
revascularization early after myocardial infarction noted an
increased operative mortality compared with that in other
patients undergoing revascularization months or years after
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occurrence of major arrhythmias or perioperative in-
farction was noted in 30 patients (29%)(64% in Group
A, 33% in Group Band 18% in Group C). The average
time in the intensive care unit was 3.2 days, with an
average total hospital stay after surgery of 8.3 days.
Late follow-up (mean 15.4 months, range 1 to 39) is
complete for 97 patients (97%). There were no late myo-
cardial infarctions and 93 patients (96%) were essen-
tially free of angina. The only late death (1.0%) was
caused by septicemia from delayed sternal wound infec-
tion. This study suggests that myocardial revasculari-
zation within the first 30 days after myocardial infarction
can be accomplished with an acceptable operative mor-
tality in selected patients with postinfarction angina re-
fractory to medical management.
infarction. However, continuing improvement in surgical
techniques and development of effective methods of intra-
operative myocardial protection have restored enthusiasm
among some surgeons for revascularization in patients with
angina early after myocardial infarction. A relatively large
recent experience at one institution reported by Jones et al.
(13) suggests that early surgery for postinfarction angina is
effective and can be accomplished with low operative mor-
tality. Other published reports of findings in large patient
groups to substantiate this experience have been lacking,
however.
Our belief has been that early revascularization in patients
with postinfarction angina is indeed effective and can be
accomplished with reasonable risk. We have, therefore, of-
fered these patients the option of early surgical revascular-
ization for angina refractory to medical management without
regard to the time interval between infarction and surgery.
Our recent experience with this patient group is the subject
of this report.
Methods
Patients. From January 1979 to July 1982, 103 patients
underwent myocardial revascularization within 30 days of
a documented acute myocardial infarction. There were 84
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A. Distribution of Transmural and Subendocardial Infarction
Transmural 4 4 II 19(18%)
Subendocardial 7 17 60 84(82%)
Total II 21 71 103
B. Anatomic Site of Infarction
Inferior 8 6 32 46(45%)
Anterior 3 14 36 53(51%)
Lateral 0 1 3 41(4%)
Total 11 21 71 103
Figures in parentheses indicate percent of the total number of 103
patients treated surgically.
men (82%) and 19 women (18%) with an average age of
58 years (range 34 to 80). For purposes of comparison, the
patient group is divided into three subgroups. Patients in
Group A underwent surgery within 24 hours of infarction
( I I patients , 11%) . Patients in Group B underwent surgery
within I to 7 days of infarction (2 1 patients , 20%) and
patients in Group C underwent surgery 7 to 30 days after
infarction (7 1 patients , 69%).
Myocardial infarction patterns (Table JA). Myocardial
infarction before revas cularization was transmural in 19 pa-
tients ( 18%) and subendocardial in 84 patients (82%) . Tran s-
mural myocardial infarction was documented by new Q
waves on the electrocardiogram in 3 patients (16%), by
creatine kinase (CK) enzyme elevations in 2 patients (11%)
and by a combination of electrocardiographic and enzyme
change s in 14 patients (73 %). Subendocardial myocardial
infarction was documented by electrocardiographic changes
in 20 patients (24% ), by creatine kinase enzyme elevations
in II patients (13%) and by a combination of electrocar-
diographic and enz yme chan ges in 53 patients (63%) . Of
the II patients in Group A, 4 (36%) had transmural myo-
cardial infarction and 7 (64%) had subendocardial myo-
cardial infarction. Of the 21 patient s in Group B, 4 (19%)
had transmural and 17 (8 1%) had subendocardial myocardial
infarction . Of the 71 patients in Group C, 11 (19%) had
transmural and 60 (81 %) had subendocardial myocardi al
infarcti on . Transmural myocard ial infarction was more fre-
quent in pat ient s in Group A than in patients in either Group
B or Group C , but the differences are not statistically sig-
nificant (probability [p] < 0.05 ).
Dominant anatomic site of myocardial infarction oc-
curring before revascularization (Table IB). These data
were obtained from preoperative electrocardiograms that
were correlated with the appearance of the heart at the time
of surgery. Of the 103 patients, 46 (45%) had an infarct
that was predominantly inferior, 53 (5 1%) had an anterior
infarct and 4 (4% ) had a lateral infarct. A total of 58 patients
had one or more myocardial infarctions before the infarction
Table I. Myocardial Infarction Patterns in 103 Patients
lead ing to myocardial revascular ization. Of these 58 pa-
tients, 43 (74%) had one prior documented myocardial in-
farction (3 patients in Group A , 6 in Group Band 34 in
Group C), 13 (22%) had two prior documented infarctions
(3 in Group A, none in Group Band 10 in Group C) and
2 (4%) had three or more prior docum ented infarctions (none
in Group A, 1 in Group B and I in Group C). Therefore,
(55%) of the 11 Group A pat ients had one or more prior
myocardial infarctions , while 7 (33%) of the 2 1 Group B
and 45 (63%) of the 71 Group C pat ients had prior myo-
card ial infarctions.
Indications for revascularization. Three patients in
Group A underwent urgent revascularization for acute evolving
myocardial infarction that began during cardiac catheter-
ization . In one of these three patients, the acute evolving
infarction developed during an attempted percutaneous tran s-
luminal coronary angioplasty . The indication for myocardial
revasculari zation in the remainin g 100 patients was angina
pectoris. Eight patients in Group A underwent surgery within
24 hours of infarction because of persistent or recurrent
angina that the referring cardio logist considered uncontroll-
able. The remaining 92 patients underwent revasculariza-
tion within 1 to 30 days of infarction for angina that the
referring cardiologist considered poorly controlled by med-
ical measures and sufficiently disabling to warrant surgical
intervention.
Catherization data (Table 2). All pat ients underwent
cardiac catheterization subsequent to sustaining their myo-
cardia l infarction and before myocardial revascularizat ion .
Coronary angio grams were reviewed and anatomic disease
reduc ing arterial lumenal diameter by 50 to 60% or greater
was considered significant. Patient s were classified as hav-
ing single vessel, double vessel , triple vessel, left main and
combined left main and right coronary artery disease. Left
ventricular ejection fraction determined from biplane left
ventri cular angiograms was availabl e for 89 (86%) of the
103 patient s and left ventricular end-diastolic pressure was
ava ilable for 82 patients (80%).
Surgery. All patients underwent myocardial revascu-
larization on cardiopulmonary bypass (2.4 liters/min per m2
with moderate core hypotherm ia [30 to 32°C]). Mo st pa-
tients had proximal anastomoses performed first while on
full bypass with the heart beating quietly . Distal anasto-
moses were performed after the aorta was occluded and the
heart arrested with a cold (4°C) balanced electrol yte solution
(potass ium adjusted to 20 mEq/liter) infused into the root
of the aorta. The cardioplegia was supplemented by bathin g
the heart with topic al co ld Ringer ' s lactate solution. Ad-
ditional cardiopleg ic solution was infused at 20 to 30 minute
intervals during aorti c occlusion .
Electrocardiograms and creatine kinase isoenzyme de-
terminations were performed immediately on return to the
intensive care unit and at 6 and 24 hours postoperatively .
The presence of new Q waves on the postoperative electro-
TotalGroup CGroup BGroup A
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Table 2. Cardiac Catheter izat ion Data
Group A Group B Group C Total
Anatorruc coronary
artery disease
Single vessel 0 3 6 9(90/cl*
Double vessel 4 6 16 26(25%)*
Tnple vessel 4 10 38 52(50'!H *
Left main 0 I 0 1(1 ~Ic ) *
Left main and nght 3 1 11 15(15%)*
Total II 21 71 103
Ejection fraction (% )
20 I 2 0 3(3%)t
20-30 I I 6 8(9%)t
30- 40 0 4 10 14(16~/cl t
40-50 4 4 18 36(29%)t
50-60 I 3 20 24(2YIc)t
> 60 I 2 II 14(16~/~)t
Total 8 16 65 89
Left ventncular end-diastolic
pressure (rnm Hg )
10 0 I 6 7(90/0)t
10-1 5 5 3 21 29(350/clt
15-20 I 6 17 24(29°Ic)t
> 20 2 7 13 22(270/clt
Total 8 17 57 82
Figures In parentheses indicate percent of (*) the total of 103 patients
undergoing surgery; (t ) the total of 89 patients with ejection fraction data
available, (t ) the total of 82 patients with left ventncular end-diastohc
pressure data available.
cardiogram after surgery was considered indicative of peri-
operative myocardial infarction . Patients with a maximal
postoperative creatinine kinase MB fraction greater than 30
units but no new Q waves underwent technetium pyro-
phosphate imagingto assess the presence of new myocardial
injury.
An average of3. J (range J to 7) distal anastomoseswere
performed per patient. The average number of distal an-
astomoses was essentially the same in the three groups (3.0
in Group A, 2.9 in Group B and 3.2 in Group C). Seventeen
Table 3. Morbidity and Earl y (30 day ) Mort ality In 103 Patients
patients (17%) received a single distal anastomosis and the
distribution by groups for single distal anastomosis was
similar (9% in Group A, 19% in Group Band 17% in Group
C). Fifty patients (49%) received three or more distal an-
astomoses and the distributionby groups was similar as well
(73% in Group A, 62% in Group Band 66% in Group C) .
Results
Mortality (Table 3). Among the 103 patients, there were
two deaths (1.9%) within 30 days of surgery (both deaths
were in patients in Group C). There were no intraoperative
deaths. One death occurred in a 57 year old man who sus-
tained an anterior myocardial infarction on August26, 1980
and subsequently had unstable angina. He underwent an
uneventful four vessel myocardial revascularization using
halothane anesthesia on September 12, 1980. On the sixth
postoperative day, he developed a hepatitis-like syndrome
with dramatic elevations of his serum hepatic enzymes. On
the 7th postoperative day, he became comatose and sub-
sequently died on the 11 th postoperative day presumably
from ' 'halothane hepatitis. "
The second death occurred in a 79 year old man who
sustained on August 4, 1981 an anterior myocardial infarc-
tion complicated by cardiogenic shock. Subsequently, he
had persistent angina that could not be controlled satisfac-
torily. He underwent an uneventful four vessel myocardial
revascularization on August 20, 1981 and had a slow con-
valescence. On the 18th postoperative day, he sustained a
cardiac arrest when his temporary pacing wires were re-
moved. Cardiopulmonary resuscitation was unsuccessful and
it was presumed that he bled into the pericardial space and
suffered fatal tamponade. Permission for autopsy was denied.
Morbidity (Table 3). Patients were considered to have
significant perioperative morbidity if inotropic agents were
required, if intraaortic balloon pumping was used or if sig-
nificant ventricular arrhythmias (multifocal ventricular pre-
Morbidity
Need for Inotropic agents






In-hospital ( :s 30 days after surgery)













Group B Group C Total
5 14 24(23%)*
2 2 70 %)*
2 II 16(16%)*
0 0 I(I o/c)*





Figures in parentheses indicate the percent of (*) the total of 103 patients undergomg surgery and (t) the percent of the number of patients In that
group (A = II , B = 21, C=71)
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mature complexes, ventricular tachycardia or ventricular
fibrillation) occurred requiring sustained pharmacologic
treatment, or if the patient had a perioperative myocardial
infarction. Twenty-four (23%) of the 103 patients required
inotropic support postoperatively. Among these 24 patients,
2 were being supported with inotropic agents before surgery
and it was necessary to continue this support postopera-
tively. All of these 24 patients survived. Seven patients (7%)
were supported with intraaortic balloon pumping postop-
eratively with all seven having required such support pre-
operatively; all of these patients survived. Sixteen patients
(16%) required pharmacologic treatment of significant ven-
tricular arrhythmia postoperatively, and 10 of these 16 pa-
tients were receiving antiarrhythmic therapy before surgery;
all 16 patients survived. One patient had a perioperative
myocardial infarction as evidenced by new Q waves and
creatin kinase MB fraction enzyme elevations.
Seven (64%) of the 11 patients in Group A, 7 (33%) of
the 21 patients in Group Band 18 (25%) of the 71 patients
in Group C experienced events that placed them in one or
more categories of morbidity. For this reason, the total
number of patients included in Table 3 is less than the
cumulative number of morbid events. Comparison of the
mean differences in the number of patients in each group
sustaining one or more category of morbidity shows that
patients in Group A had a significantly increased incidence
of morbidity compared with those in Groups Band C (p <
0.05).
Follow-up (Table 4). Follow-up data were obtained by
either telephone or mail contact with the patient or the re-
ferring cardiologist. Follow-up was complete for 97 patients
(94%) with a total of 1,494 patient-months (mean 15.4,
range 1 to 39). The mean follow-up period was 8.3 months
for Group A, 15.3 months for Group Band 16.5 months
Table 4. Summary of Follow-up Data on 97 Patients
Group A Group B Group C Total
for Group C. There was one late death (1%) in the 97 patients
with complete follow-up. This patient from Group C died
from septicemia related to a relatively late presenting sternal
wound infection. No late myocardial infarctions were noted.
Ninety-six percent of the 97 patients are essentially pain-
free (90% in Group A, 95% in Group Band 97% in Group
C) while the remaining 4 patients (4%) have stable exertional
angina (10% in Group A, 5% in Group Band 3% in Group
C).
Preoperative New York Heart Association functional class
data were available on all 103 patients undergoing revas-
cularization. Three patients (3%) were in functional class
II, 36 (35%) in class III and the remaining 64 (62%) in class
IV. All 11 patients in Group A were considered to be in
class IV. Postoperative functional class data are available
on 97 patients and of this group 93 (96%) are in class I, 3
(3%) in class II and 1 (I %) in class III with regard to angina.
No patient is in class IV postoperatively.
Hospitalization (Table 5). The average duration of hos-
pital stay for the entire group of patients from the day of
surgery to discharge was 8.3 days. There was essentially
no difference between groups in length of hospital stay. The
average length of care in the intensive care unit was 3.2
days and did not differ significantly in the three groups.
Discussion
A number of reports (14-18) suggest that appropriately
applied medical therapy may reduce the size of a myocardial
infarction, which implies that salvageable myocardium may
remain in or near the infarcted area and this viable tissue
may be subject to recurrent or persistent ischemia. More
than half of patients with postinfarction angina have electro-
cardiographic changes in the area of the original infarction,
Deaths 0 0 1(1 0%)*
Symptoms Table 5. Summary of Data on Length of Hospitalization
Pam-free 9 19 65 93(96%)* Group A Group B Group C Total
Stable angina 1 1 2 4(4%)*
Unstable angina 0 0 0 0 Days in intensive care umt
Preoperative functional class :0;2 6 12 43 61(59%)t
I 0 0 0 2-5 4 9 20 33(32%)
II 0 I 2 3(3%)t >5 I 0 8 9(9%)
III 0 6 30 36(35%)t Average 2.9 2.8 3.4 3.2 days!
IV II 14 39 64(62%)t patient
Postoperative functional Days in hospital
class :0;5 0 0 8 8(10%)+
I 9 19 65 64(62%)* 5-10 6 14 32 52(67%)
II 0 1 2 3(3%)* >10 2 4 12 18(23%)
III I 0 0 1(1%)* Average 8.4 8.3 8.3 8.3 days!
IV 0 0 0 0 patient
Figures inparentheses indicate the percent of(*) the total of97 patients Figures inparentheses mdicatethe percent of(t) the total of103patients
with complete follow-up and (t) the total of 103 patients undergoing and (+) the total of78 patients completing hospitahzation, which excludes
surgery. 25 patients transferred toother facilities for care.
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and most of these patients develop recurrent angina within
the first 36 hours after infarction (19). Hence, some patients
who have received prompt medical therapy may, in fact,
develop persistent or recurrent angina related to residual
ischemic, yet viable, myocardium. As our abilityto interrupt
the process of myocardial necrosis continues to improve ,
the numberof patients with symptoms of angina early after
infarction may increase.
Early surgery may be an attractive option in some
patients with postinfarction angina. Eventhough prompt ,
aggressive medical therapy may decrease infarct size in
many instances , continued medical management of some
patients with postinfarction angina has not proved satisfac-
tory (20). The presence of ischemic, yet viable, myocardium
in a patient with angina early after an infarction places that
patient at increased risk for infarct extension. Although the
incidence of extension of an acute myocardial infarction
varies widely depending on patient population, the criteria
for diagnosis and the method of detection, it is clear that
infarct extension carries a poor prognosis for both the short
and long term (3). The incidence of infarct extension has
been reported to be between 13 and 86% (1-4 ), occurs an
average of 3.4 days after infarction and carries a mortality
of 36 versus 9% for patients withoutextension (3). Itappears
that patients with postinfarction angina should be placed in
a special category at high risk for both Immediate and late
complications, including infarct extension, arrhythmia, shock
and death. Early surgical myocardial revascularization in
this group becomes a theoretically attractive option if isch-
emic myocardiumcan be salvaged and infarct extension and
its attendant complications reduced.
Subendocardial infarction. Approximately one-half of
patients withsubendocardial myocardial infarction haveper-
sistent angina after infarction (2 1). Although the early mor-
tality associated with acute transmural infarction is approx-
imately double that of subendocardial infarction (29 vs.
14%) (25 ), subsequent infarction, however, is significantly
higher in the subendocardial group (26 to 46 %) than in the
transmural group (10 to 12%)(8, 21-24). Recent data sug-
gest that almost one-half of patients with subendocardial
infarction will have an infarct extension an average of 10
days after the initial event (25 ). Subendocardial myocardial
infarction is usually associated with two or three vessel
disease, and many patients have well preserved ventricular
function (2I).
In light of the poor prognosis associated with subendo-
cardial infarction and the likelihood of severe coronary dis-
ease, we have adopted an aggressive attitude similar to that
of others (26) toward early recurrent symptoms in this pa-
tient group. Eighty-two percent of the patients in our series
had subendocardial infarction with angina that was not ef-
fectively controlled by medical measures. During the short
time interval of follow-up in this series, patients with sub-
endocardial infarction have had no documented infarction
and only 4% have had recurrent angina after surgery.
Morbidity and mortality. The early reports (5-12) of
myocardial revascularization carried out soon after myo-
cardial infarction noted a greatly increased operative mor-
tality. Furthermore , it has been reported (10 ) that patients
treated surgically within the first 7 days after infarction
experienced twice the mortality of those treated surgically
after 8 to 30 days and more than threefold the mortality of
those treated surgically more than 30 days after infarction.
It was not until 1978 that Jones et al. (27) reported a series
of 35 patients who underwent revascularization within 30
days of infarction without an early or late death. This ad-
mirable series has since been updated (1981) to 116patients
without a hospital death (13). Other smaller series (4,28)
reported during the same time frame suggest a mortality
rate in the range of 7 to 9%. The mortality rate in our series
of I .9% parallels the experience of Jones et al. (13,27) and
is comparable with our own overall mortality rate of 1.2%
for myocardial revascularization in patients without infarction.
Although operative mortality is probably not increased
in patients undergoing revascularization within the first 24
hours after infarction, the incidence of perioperative com-
plications appears to be somewhat increased in this group
compared with those operated on I to 30 days after infarc-
tion. On the basis of our data and those of others (13),
patients who undergo surgery within the first 24 hours are
more likely to require inotropic support, intraaortic balloon
pumping and pharmacologic management of significant ar-
rhythmia or have a perioperative myocardial infarction. No
doubt these patients who come to surgery earlier are more
clinically unstable and, hence, more likely to encounter
perioperative complications. Nevertheless, we believe that
urgent revascularization can be safely accomplished if nec-
essary within 24 hours after myocardial infarction.
Usc of the intraaortic balloon. Seven patients in this
series required support with the intraaortic balloon before
surgery, and this support was continued throughout the peri-
operative period. In general, it has beenour practice to limit
the use of the intraaortic balloon pump to patients in car-
diogenic shock or those manifesting significant hemody-
namic dysfunction associated with angina. We agree with
Brundage et at. (4) that the intraaortic balloon pump is not
required in most patients undergoing revascularization early
after myocardial infarction. Nevertheless, ourdata and those
of others (29) confi rm that intraaortic balloon pump support
is indeed useful in managingcardiogenic shock or significant
ventricular dysfunction. Patients who are hemodynamically
unstable should have intraaortic balloon pump support in-
itiatedbeforecatheterization withsupport carried throughout
the perioperative period.
Indications for surgery. At present, the indication for
myocardial revascularization early after myocardial infarc-
tion is disabling angina that is refractory to medical man-
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agement. Essentially all patients in the present series under-
went revascularization because of angina that could not be
effectively controlled. During the relatively short follow-up
period of the present series, early surgery appears to sat-
isfactorily relieve disabling symptoms of angina. However,
the long-term benefits of early surgery after myocardial in-
farction in terms of preventing recurrent infarction or death
cannot be determined from the retrospective data in this
report because of the relatively short follow-up period. Fur-
thermore, a randomized study between early surgery and
continued medical management is perhaps the only way to
provide clear insight into the relative merits of early surgery.
Nevertheless, selected patients in whom medical therapy
has failed can undergo revascularization early after myo-
cardial infarction with low operative risk.
Conclusion. Our data suggest that myocardial revas-
cularization performed within 30 days after acute myo-
cardial infarction can be accomplished with reasonable risk
in selected patients with postinfarction angina. The inci-
dence of perioperative complications appears to be increased
in those patients operated on within 24 hours of their in-
farction compared with those operated on I to 30 days after
their infarction.
We gratefully acknowledge the assistance of Linda Holman in preparation
of the manuscript.
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